Home » Stocks » Rockwell Medical

Rockwell Medical, Inc. (RMTI)

Stock Price: $1.67 USD -0.01 (-0.60%)
Updated Aug 7, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 115.35M
Revenue (ttm) 61.60M
Net Income (ttm) -33.43M
Shares Out 69.07M
EPS (ttm) -0.53
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $1.67
Previous Close $1.68
Change ($) -0.01
Change (%) -0.60%
Day's Open 1.67
Day's Range 1.61 - 1.70
Day's Volume 464,605
52-Week Range 1.31 - 3.85

More Stats

Market Cap 115.35M
Enterprise Value 66.68M
Earnings Date (est) Aug 10, 2020
Ex-Dividend Date n/a
Shares Outstanding 69.07M
Float 64.59M
EPS (basic) -0.53
EPS (diluted) -0.53
FCF / Share -0.43
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 5.73M
Short Ratio 11.23
Short % of Float 11.86%
Beta 1.54
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 1.87
PB Ratio 5.61
Revenue 61.60M
Operating Income -33.77M
Net Income -33.43M
Free Cash Flow -29.04M
Net Cash 48.67M
Net Cash / Share 0.70
Gross Margin 4.61%
Operating Margin -54.82%
Profit Margin -54.30%
FCF Margin -47.14%
ROA -36.06%
ROE -159.45%
ROIC -169.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$10.00*
(498.80% upside)
Low
9.00
Current: $1.67
High
11.00
Target: 10.00
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2019201820172016201520142013201220112010
Revenue61.3063.3957.3053.2855.3554.1952.3849.8448.9759.55
Revenue Growth-3.29%10.63%7.54%-3.73%2.14%3.45%5.09%1.79%-17.78%-
Gross Profit2.84-1.583.706.758.948.556.666.695.649.86
Operating Income-34.53-32.44-25.92-20.21-15.10-17.56-47.06-54.26-21.68-2.87
Net Income-34.13-32.13-25.92-19.80-14.42-21.33-48.78-54.02-21.44-2.68
Shares Outstanding60.9252.8251.0751.5351.0843.6040.0021.3018.6717.46
Earnings Per Share-0.56-0.61-0.51-0.39-0.29-0.52-1.48-2.65-1.21-0.16
Operating Cash Flow-27.25-20.42-21.11-12.45-13.334.26-50.66-30.75-10.782.10
Capital Expenditures-0.59-0.74-1.68-0.36-0.82-0.68-0.65-0.51-0.42-0.77
Free Cash Flow-27.84-21.16-22.80-12.81-14.143.57-51.32-31.25-11.201.33
Cash & Equivalents26.0433.5333.0657.9470.6885.7323.924.7117.5324.20
Total Debt0.76-----20.23-0.010.03
Net Cash / Debt25.2833.5333.0657.9470.6885.733.694.7117.5224.17
Assets44.3252.5658.7883.1587.8298.0036.3617.0331.9436.97
Liabilities24.0025.2825.8730.2025.5029.3035.7726.9913.696.43
Book Value20.3227.2832.9152.9662.3268.700.60-9.9618.2430.54
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Rockwell Medical, Inc.
Country United States
Employees 299
CEO Russell H. Ellison

Stock Information

Ticker Symbol RMTI
Stock Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier NASDAQ: RMTI
IPO Date January 27, 1998

Description

Rockwell Medical, Inc. operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis. The company offers Triferic, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores; and Calcitriol, an active vitamin D injection for the management of hypocalcemia in patients undergoing chronic hemodialysis. It is also developing an intravenous formulation of Triferic for use by hemodialysis patients. In addition, the company manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers. Its dialysis concentrate products are used to maintain human life by removing toxins and replacing critical nutrients in the dialysis patient's bloodstream. Rockwell Medical, Inc. sells its products directly, as well as through independent sales agents and distributors. Its target customers include senior and operating management of dialysis companies, dialysis service providers, nephrologists, clinic administrators, nurses, medical directors, and technical and purchasing personnel. Rockwell Medical, Inc. was founded in 1994 and is based in Wixom, Michigan.